Biotech

All Articles

Sanofi fails MS study, inflicting yet another impact to Denali deal

.Sanofi has stopped a phase 2 ordeal of Denali Therapeutics-partnered oditrasertib in various sclero...

Turnstone gives up 60%, agitates C-suite to stretch out cash money

.Turnstone Biologics is decreasing its head count through 60% as well as shocking its own C-suite so...

Gilead quits on $15M MASH wager after mulling preclinical records

.In a year that has actually observed an approval and a range of readouts for metabolic dysfunction-...

Texas biotech axes cancer cells treaty, pins hopes on being overweight

.Alaunos Rehabs is axing an arrangement with Precigen, quiting licensing legal rights to a tailored ...

Capricor portions much more data for DMD treatment after initiating BLA

.Capricor Therapeutics is taking a success tour for their phase 2 Duchenne muscular dystrophy (DMD) ...

FDA spots Kezar lupus trial in grip following 4 person deaths

.The FDA has placed Kezar Lifestyle Sciences' lupus test on hold after the biotech warned four fatal...

Phase 3 Scholar Stone trial attacks SMA goal, sending stockpile 200%

.A phase 3 test of Intellectual Rock's spine muscle atrophy (SMA) candidate has actually hit its pri...

CAMP 4 is actually latest to eye IPO, while Upstream point out $182M program

.RNA biotech CAMP4 Therapies has actually defined think about a $67 million IPO, along with inflamma...

Galecto purchases leukemia medication, drops bone tissue cancer possession in pivot

.A year after the failure of an idiopathic lung fibrosis applicant sent out Galecto on a seek redemp...

Judo tosses down $100M to knock out kidney condition

.Taking the mat is actually Judo Bio, an up-and-coming biotech equipped along with $one hundred thou...